Your browser doesn't support javascript.
loading
Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease: Pooled De Novo Results From 15 Observational Studies.
Laguzzi, Federica; Åkesson, Agneta; Marklund, Matti; Qian, Frank; Gigante, Bruna; Bartz, Traci M; Bassett, Julie K; Birukov, Anna; Campos, Hannia; Hirakawa, Yoichiro; Imamura, Fumiaki; Jäger, Susanne; Lankinen, Maria; Murphy, Rachel A; Senn, Mackenzie; Tanaka, Toshiko; Tintle, Nathan; Virtanen, Jyrki K; Yamagishi, Kazumasa; Allison, Matthew; Brouwer, Ingeborg A; De Faire, Ulf; Eiriksdottir, Gudny; Ferrucci, Luigi; Forouhi, Nita G; Geleijnse, Johanna M; Hodge, Allison M; Kimura, Hitomi; Laakso, Markku; Risérus, Ulf; van Westing, Anniek C; Bandinelli, Stefania; Baylin, Ana; Giles, Graham G; Gudnason, Vilmundur; Iso, Hiroyasu; Lemaitre, Rozenn N; Ninomiya, Toshiharu; Post, Wendy S; Psaty, Bruce M; Salonen, Jukka T; Schulze, Matthias B; Tsai, Michael Y; Uusitupa, Matti; Wareham, Nicholas J; Oh, Seung-Won; Wood, Alexis C; Harris, William S; Siscovick, David; Mozaffarian, Dariush.
Afiliação
  • Laguzzi F; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine (F.L., A.A., U.D.F., K.L.), Karolinska Institutet, Stockholm, Sweden.
  • Åkesson A; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine (F.L., A.A., U.D.F., K.L.), Karolinska Institutet, Stockholm, Sweden.
  • Marklund M; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (M.M., W.S.P).
  • Qian F; The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia (M.M.).
  • Gigante B; Section of Cardiovascular Medicine, Boston Medical Center and Boston University Chobanian and Avedisian School of Medicine, MA (F.Q.).
  • Bartz TM; Department of Nutrition (F.Q.), Boston, MA.
  • Bassett JK; Cardiovascular Medicine Unit, Department of Medicine Solna (B.G.), Karolinska Institutet, Stockholm, Sweden.
  • Birukov A; Cardiovascular Health Research Unit, Departments of Biostatistics (T.M.B.), University of Washington, Seattle.
  • Campos H; Medicine (T.M.B., R.N.L., B.M.P.), University of Washington, Seattle.
  • Hirakawa Y; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia (J.K.B., A.M.H., G.G.G.).
  • Imamura F; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal (A.K.B., S.J., M.B.S.).
  • Jäger S; German Center for Diabetes Research, Neuherberg (A.K.B., S.J., M.B.S.).
  • Lankinen M; Harvard T.H. Chan School of Public Health (H.C.), Boston, MA.
  • Murphy RA; Departments of Epidemiology and Public Health and Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (Y.H., T.N.).
  • Senn M; Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, UK (F.I., N.G.F., N.J.W.).
  • Tanaka T; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal (A.K.B., S.J., M.B.S.).
  • Tintle N; Institutes of Public Health and Clinical Nutrition (M. Lankinen, J.K.V., M.U.), University of Eastern Finland, Kuopio.
  • Virtanen JK; Cancer Control Research, BC Cancer Agency, Vancouver, Canada (R.A.M.).
  • Yamagishi K; School of Population and Public Health, University of British Columbia, Vancouver, Canada (R.A.M.).
  • Allison M; United States Department of Agriculture/Agricultural Research Service Children's Nutrition Research Center, Baylor College of Medicine, Houston, TX (M.S., A.C.W.).
  • Brouwer IA; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany (M.B.S.).
  • De Faire U; Longitudinal Study Section, National Institute on Aging, Baltimore, MD (T.T., L.F.).
  • Eiriksdottir G; Fatty Acid Research Institute, Sioux Falls, SD (N.T., W.S.H.).
  • Ferrucci L; Department of Population Health Nursing Science, University of Illinois - Chicago (N.T.).
  • Forouhi NG; Institutes of Public Health and Clinical Nutrition (M. Lankinen, J.K.V., M.U.), University of Eastern Finland, Kuopio.
  • Geleijnse JM; Department of Public Health Medicine, Institute of Medicine (K.Y., H.K.), University of Tsukuba, Japan.
  • Hodge AM; Health Services Research and Development Center (K.Y., H.K.), University of Tsukuba, Japan.
  • Kimura H; Department of Family Medicine, University of California, San Diego, La Jolla (M.A.).
  • Laakso M; Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, The Netherlands (I.A.B.).
  • Risérus U; Amsterdam Public Health Research Institute, The Netherlands (I.A.B.).
  • van Westing AC; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine (F.L., A.A., U.D.F., K.L.), Karolinska Institutet, Stockholm, Sweden.
  • Bandinelli S; Icelandic Heart Association, Kopavogur (G.E., V.G.).
  • Baylin A; Longitudinal Study Section, National Institute on Aging, Baltimore, MD (T.T., L.F.).
  • Giles GG; Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, UK (F.I., N.G.F., N.J.W.).
  • Gudnason V; Division of Human Nutrition and Health, Wageningen University and Research, The Netherlands (J.M.G., A.C.v.W.).
  • Iso H; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia (J.K.B., A.M.H., G.G.G.).
  • Lemaitre RN; Centre for Epidemiology and Biostatistics, University of Melbourne, Victoria, Australia (A.M.H., G.G.G.).
  • Ninomiya T; Department of Public Health Medicine, Institute of Medicine (K.Y., H.K.), University of Tsukuba, Japan.
  • Post WS; Health Services Research and Development Center (K.Y., H.K.), University of Tsukuba, Japan.
  • Psaty BM; Clinical Medicine, Internal Medicine (M. Laakso), University of Eastern Finland, Kuopio.
  • Salonen JT; Kuopio University Hospital (M. Laakso), University of Eastern Finland, Kuopio.
  • Schulze MB; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Sweden (M.M., U.R).
  • Tsai MY; United States Department of Agriculture/Agricultural Research Service Children's Nutrition Research Center, Baylor College of Medicine, Houston, TX (M.S., A.C.W.).
  • Uusitupa M; Division of Human Nutrition and Health, Wageningen University and Research, The Netherlands (J.M.G., A.C.v.W.).
  • Wareham NJ; Geriatric Unit, Azienda Unità Sanitaria Locale Toscana Centro, Florence, Italy (S.B.).
  • Oh SW; University of Michigan School of Public Health, Ann Arbor (A. Baylin).
  • Wood AC; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia (J.K.B., A.M.H., G.G.G.).
  • Harris WS; Centre for Epidemiology and Biostatistics, University of Melbourne, Victoria, Australia (A.M.H., G.G.G.).
  • Siscovick D; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Victoria, Australia (G.G.G.).
  • Mozaffarian D; Icelandic Heart Association, Kopavogur (G.E., V.G.).
Circulation ; 149(4): 305-316, 2024 01 23.
Article em En | MEDLINE | ID: mdl-38047387
BACKGROUND: It is unknown whether dietary intake of polyunsaturated fatty acids (PUFA) modifies the cardiovascular disease (CVD) risk associated with a family history of CVD. We assessed interactions between biomarkers of low PUFA intake and a family history in relation to long-term CVD risk in a large consortium. METHODS: Blood and tissue PUFA data from 40 885 CVD-free adults were assessed. PUFA levels ≤25th percentile were considered to reflect low intake of linoleic, alpha-linolenic, and eicosapentaenoic/docosahexaenoic acids (EPA/DHA). Family history was defined as having ≥1 first-degree relative who experienced a CVD event. Relative risks with 95% CI of CVD were estimated using Cox regression and meta-analyzed. Interactions were assessed by analyzing product terms and calculating relative excess risk due to interaction. RESULTS: After multivariable adjustments, a significant interaction between low EPA/DHA and family history was observed (product term pooled RR, 1.09 [95% CI, 1.02-1.16]; P=0.01). The pooled relative risk of CVD associated with the combined exposure to low EPA/DHA, and family history was 1.41 (95% CI, 1.30-1.54), whereas it was 1.25 (95% CI, 1.16-1.33) for family history alone and 1.06 (95% CI, 0.98-1.14) for EPA/DHA alone, compared with those with neither exposure. The relative excess risk due to interaction results indicated no interactions. CONCLUSIONS: A significant interaction between biomarkers of low EPA/DHA intake, but not the other PUFA, and a family history was observed. This novel finding might suggest a need to emphasize the benefit of consuming oily fish for individuals with a family history of CVD.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Ácidos Graxos Ômega-3 Limite: Animals Idioma: En Revista: Circulation Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Ácidos Graxos Ômega-3 Limite: Animals Idioma: En Revista: Circulation Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suécia